Advertisement

Debates in Dacryology: The Mitomycin-C Dilemma

  • Yi-fan Feng
Chapter

Abstract

The most common reason for the failure of dacryocystorhinostomy (DCR) surgery is the formation of scar or granulation tissue over the osteotomy site. From the literature, it is clear that fibrous tissue growth, scarring, and granulation tissue formation during the healing process will decrease or compromise the created surface area of the osteotomy site, leading to surgical failure [1, 2]. Also, the healing process has the potential to promote adhesion of the osteotomy to the middle turbinate and septum, or induce obstruction of the common canaliculus [3]. Thus, if we can inhibit fibrous tissue growth and scarring by applying anti-proliferative agents over the anastomosed flaps and osteotomy site, the failure rate may be minimized [4].

Keywords

Middle Turbinate Osteotomy Site Nasolacrimal Duct Obstruction Extensive Cell Death Silicone Intubation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Allen KM, Berlin AJ, Levine HL. Intranasal endoscopic analysis of dacrocystorhinostomy failure. Ophthal Plast Reconstr Surg. 1988;4:143–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Jokinen K, Karja J. Endonasal dacryocystorhinostomy. Arch Otolaryngol. 1974;100:41–4.PubMedCrossRefGoogle Scholar
  3. 3.
    McLachlan DL, Shannon GM, Flanagan JC. Results of dacryocystorhinostomy: analysis of the reoperations. Ophthalmic Surg. 1980;11:427–30.PubMedGoogle Scholar
  4. 4.
    Liao SL, Kao SC, Tseng JH, et al. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol. 2000;84:903–6.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Verweij J, Pinedo HM. Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs. 1990;1:5–13.PubMedCrossRefGoogle Scholar
  6. 6.
    Reddy MV, Randerath K. 32P-analysis of DNA adducts in somatic and reproductive tissues of rats treated with the anticancer antibiotic, mitomycin C. Mutat Res. 1987;179:75–88.PubMedCrossRefGoogle Scholar
  7. 7.
    Maestrini HA, Cronemberger S, Matoso HD, et al. Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium. Ophthalmology. 2011;118:755–62.PubMedCrossRefGoogle Scholar
  8. 8.
    Reibaldi A, Uva MG, Longo A. Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma. Br J Ophthalmol. 2008;92:1666–70.PubMedCrossRefGoogle Scholar
  9. 9.
    Young AL, Ho M, Jhanji V, et al. Ten-year results of a randomized controlled trial comparing 0.02 % mitomycin C and limbal conjunctival autograft in pterygium surgery. Ophthalmology. 2013;120:2390–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Diaz L, Villegas VM, Emanuelli A, et al. Efficacy and safety of intraoperative mitomycin C as adjunct therapy for pterygium surgery. Cornea. 2008;27:1119–21.PubMedCrossRefGoogle Scholar
  11. 11.
    Chen SH, Feng YF, Stojanovic A, et al. Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02 % mitomycin C. J Refract Surg. 2011;27:530–41.PubMedCrossRefGoogle Scholar
  12. 12.
    Xue K, Mellington FE, Norris JH. Meta-analysis of the adjunctive use of Mitomycin C in primary and revision, external and endonasal dacryocystorhinostomy. Orbit. 2014;33:239–44.Google Scholar
  13. 13.
    Feng YF, Yu JG, Shi JL, et al. A meta-analysis of primary external dacryocystorhinostomy with and without mitomycin C. Ophthalmic Epidemiol. 2012;19:364–70.PubMedCrossRefGoogle Scholar
  14. 14.
    Occleston NL, Daniels JT, Tarnuzzer RW, et al. Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behaviour. Invest Ophthalmol Vis Sci. 1997;38:1998–2007.PubMedGoogle Scholar
  15. 15.
    Kim JW, Kim SK, Song IH, et al. Mitomycin C-induced apoptosis in cultured human Tenon’s capsule fibroblasts. Korean J Ophthalmol. 1999;13:7–15.PubMedGoogle Scholar
  16. 16.
    Hu D, Chen PP, Oda D. The effect of mitomycin C after long-term storage on human Tenon’s fibroblast proliferation. J Glaucoma. 1999;8:302–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Jampel HD. Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon’s capsule fibroblasts. Ophthalmology. 1992;99:1471–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Hu D, Sires BS, Tong DC, et al. Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg. 2000;16:119–25.PubMedCrossRefGoogle Scholar
  19. 19.
    Ali MJ, Mariappan I, Maddileti S, et al. Mitomycin C in dacryocystorhinostomy: the search for the right concentration and duration–a fundamental study on human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg. 2013;29:469–74.PubMedCrossRefGoogle Scholar
  20. 20.
    Ingrams DR, Volk MS, Biesman BS, et al. Sinus surgery: does mitomycin C reduce stenosis? Laryngoscope. 1998;108:883–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Rahal A, Peloquin L, Ahmarani C. Mitomycin C in sinus surgery: preliminary results in a rabbit model. J Otolaryngol. 2001;30:1–5.PubMedCrossRefGoogle Scholar
  22. 22.
    Kavuzlu A, Arslan N, Tastan E, et al. The effects of repetitious topical use of mitomycin C on antrostomy patency in maxillary antrostomy created rabbit model. Eur Arch Otorhinolaryngol. 2011;268:1597–603.PubMedCrossRefGoogle Scholar
  23. 23.
    Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol. 1993;116:314–26.PubMedCrossRefGoogle Scholar
  24. 24.
    Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99:1647–54.PubMedCrossRefGoogle Scholar
  25. 25.
    Kao SC, Liao CL, Tseng JH, et al. Dacryocystorhinostomy with intraoperative mitomycin C. Ophthalmology. 1997;104:86–91.PubMedCrossRefGoogle Scholar
  26. 26.
    Gonzalvo IF, Fuertes FI, Fernandez TF, et al. External dacryocystorhinostomy with mitomycin C. Clinical and anatomical evaluation with helical computed tomography. Arch Soc Esp Oftalmol. 2000;75:611–7.Google Scholar
  27. 27.
    Tirakunwichcha S, Aeumjaturapat S, Sinprajakphon S. Efficacy of mitomycin C in endonasal endoscopic dacryocystorhinostomy. Laryngoscope. 2011;121:433–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Deka A, Bhattacharjee K, Bhuyan SK, et al. Effect of mitomycin C on ostium in dacryocystorhinostomy. Clin Experiment Ophthalmol. 2006;34:557–61.PubMedGoogle Scholar
  29. 29.
    Cheng SM, Feng YF, Xu L, et al. Efficacy of mitomycin C in endoscopic dacryocystorhinostomy: a systematic review and meta-analysis. PLoS One. 2013;8:e62737.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Feng YF, Cai JQ, Zhang JY, et al. A meta-analysis of primary dacryocystorhinostomy with and without silicone intubation. Can J Ophthalmol. 2011;46:521–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Tabaee A, Brown SM, Anand VK. Mitomycin C and endoscopic sinus surgery: where are we? Curr Opin Otolaryngol Head Neck Surg. 2007;15:40–3.PubMedCrossRefGoogle Scholar
  32. 32.
    Henson RD, Cruz HL, Henson RG, et al. Post-operative application of Mitomycin-C in endocanalicular laser dacryocystorhinostomy. Ophthal Plast Reconstr Surg. 2012;28:192–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Kamal S, Ali MJ, Naik MN. Circumostial Mitomycin C (COS-MMC) in external and endoscopic dacryocystorhinostomy: Efficacy, safety profiles and outcomes. Ophthal Plast Reconstr Surg. 2014;30:187–90.PubMedCrossRefGoogle Scholar
  34. 34.
    Woog JJ, Kennedy RH, Custer PL, et al. Endonasal dacryocystorhinostomy: a report by the American Academy of Ophthalmology. Ophthalmology. 2001;108:2369–77.PubMedCrossRefGoogle Scholar
  35. 35.
    Dolmetsch AM, Gallon MA, Holds JB. Non-laser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children. Ophthal Plast Reconstr Surg. 2008;24:390–3.PubMedCrossRefGoogle Scholar
  36. 36.
    Sodhi PK, Verma L, Ratan SK. Young age – a risk factor for failure of dacryocystorhinostomy. Orbit. 2004;23:237–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Yildirim C, Yaylali V, Esme A, et al. Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy. Int Ophthalmol. 2007;27:31–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Roozitalab MH, Amirahmadi M, Namazi MR. Results of the application of intraoperative mitomycin C in dacryocystorhinostomy. Eur J Ophthalmol. 2004;14:461–3.PubMedGoogle Scholar
  39. 39.
    Yalaz M, Firinciogullari E, Zeren H. Use of mitomycin C and 5-fluorouracil in external dacryocystorhinostomy. Orbit. 1999;18:239–45.PubMedCrossRefGoogle Scholar
  40. 40.
    Eshraghy B, Raygan F, Tabatabaie SZ, et al. Effect of mitomycin C on success rate in dacryocystorhinostomy with silicone tube intubation and improper flaps. Eur J Ophthalmol. 2012;22:326–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Qadir M, Ahangar A, Dar MA, et al. Comparative study of dacryocystorhinostomy with and without intraoperative application of Mitomycin C. Saudi J Ophthalmol. 2014;28:44–8.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Ghosh S, Roychoudhury A, Roychaudhuri BK. Use of mitomycin C in endo-DCR. Indian J Otolaryngol Head Neck Surg. 2006;58:368–9.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Prasannaraj T, Kumar BY, Narasimhan I, et al. Significance of adjunctive mitomycin C in endoscopic dacryocystorhinostomy. Am J Otolaryngol. 2012;33:47–50.PubMedCrossRefGoogle Scholar
  44. 44.
    Farahani F, Ramezani A. Effect of intraoperative mitomycin C application on recurrence of endoscopic dacryocystorhinostomy. Saudi Med J. 2008;29:1354–6.PubMedGoogle Scholar
  45. 45.
    Penttila E, Smirnov G, Seppa J, et al. Mitomycin C in revision endoscopic dacryocystorhinostomy: a prospective randomized study. Am J Rhinol Allergy. 2011;25:425–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Ozkiris M, Ozkiris A, Goktas S. Effect of mitomycin C on revision endoscopic dacryocystorhinostomy. J Craniofac Surg. 2012;23:e608–10.PubMedCrossRefGoogle Scholar
  47. 47.
    Ragab SM, Elsherif HS, Shehata EM, et al. Mitomycin C-enhanced revision endoscopic dacryocystorhinostomy: a prospective randomized controlled trial. Otolaryngol Head Neck Surg. 2012;147:937–42.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2015

Authors and Affiliations

  1. 1.Department of OphthalmologyZhongshan Hospital and Fudan UniversityShanghaiChina

Personalised recommendations